CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹42 Cr | ₹34 Cr | ₹28 Cr | ₹23 Cr | ₹21 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CONCORD BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹42 Cr |
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹28 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹21 Cr |
How is Deferred Tax Assets / Liabilities of CONCORD BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹42 Cr | 24.69 | |
| Mar2025 | ₹34 Cr | 21.23 | |
| Mar2024 | ₹28 Cr | 19.74 | |
| Mar2023 | ₹23 Cr | 11.77 | |
| Mar2022 | ₹21 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,460.4 Cr | 3.7% | 8.7% | -22.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 3.7% |
8.7% |
-22.6% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses